Physics considerations in targeted anticancer drug delivery by magnetoelectric nanoparticles
Author(s) -
Emmanuel Stimphil,
Abhignyan Nagesetti,
Rakesh Guduru,
Tiffanie Stewart,
Alexandra Rodzinski,
Ping Liang,
Sakhrat Khizroev
Publication year - 2017
Publication title -
applied physics reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.084
H-Index - 66
ISSN - 1931-9401
DOI - 10.1063/1.4978642
Subject(s) - drug delivery , nanoparticle , nanotechnology , cancer , magnetic nanoparticles , mechanism (biology) , cancer therapy , computer science , bioinformatics , medicine , physics , materials science , biology , quantum mechanics
In regard to cancer therapy, magnetoelectric nanoparticles (MENs) have proven to be in a class of its own when compared to any other nanoparticle type. Like conventional magnetic nanoparticles, they can be used for externally controlled drug delivery via application of a magnetic field gradient and image-guided delivery. However, unlike conventional nanoparticles, due to the presence of a non-zero magnetoelectric effect, MENs provide a unique mix of important properties to address key challenges in modern cancer therapy: (i) a targeting mechanism driven by a physical force rather than antibody matching, (ii) a high-specificity delivery to enhance the cellular uptake of therapeutic drugs across the cancer cell membranes only, while sparing normal cells, (iii) an externally controlled mechanism to release drugs on demand, and (iv) a capability for image guided precision medicine. These properties separate MEN-based targeted delivery from traditional biotechnology approaches and lay a foundation for the comp...
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom